Sean Tchanho Hwang

Sean Tchanho Hwang

Auto-generated profile, based on publicly available information

Sean Tchanho Hwang

From the Stanford University (S.T., K.J.M.), Palo Alto, CA; Emmes (C.P.R., C.A.B., A.G.M.), Rockville, MD; Northwestern University (E.E.G.), Chicago, IL; Minnesota Epilepsy Group (P.P.), Roseville; Emory University (E.G.), Atlanta, GA; University of Cincinnati (J.C.), OH; Northwell Health (S.T.H.), New Hyde Park, NY; University of Southern California (L.A.K.), Los Angeles; Wake Forest University Health Sciences (M.S.), Winston-Salem, NC; Columbia University (A.P.), New York; and University of...

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2013 in NeuroImage
Verified
Journal Article
Closed access
DGDavid M. Groppe
David M. Groppe
SBStephan Bickel
Stephan Bickel
CKCorey J. Keller
Corey J. Keller
SJSanjay K. Jain
Sanjay K. Jain
SHSean T. Hwang
Sean T. Hwang
AMAshesh D. Mehta
Ashesh D. Mehta

16 April 2014 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
PMPierre Mégevand
Pierre Mégevand
DGDavid M. Groppe
David M. Groppe
MGMatthew S. Goldfinger
Matthew S. Goldfinger
SHSean T. Hwang
Sean T. Hwang
PKPeter B. Kingsley
Peter B. Kingsley
AMAshesh D. Mehta
Ashesh D. Mehta
In recent years, functional neuroimaging has disclosed a network of cortical areas in the basal temporal lobe that selectively respond to visual scenes, including the parahippocampal place area (PPA). Beyond the observation that lesions involving the PPA cause topographic disorientation, there is little causal evidence linking neural activity in that area to the perception of places. Here, we combined functional magnetic resonance imaging (fMRI) and intracranial EEG (iEEG) recordings to delineate place-selective cortex in a patient implanted with stereo-EEG electrodes for presurgical evaluation of drug-resistant epilepsy. Bipolar direct electrical stimulation of a cortical area in the collateral sulcus and medial fusiform gyrus, which was place-selective according to both fMRI and iEEG, induced a topographic visual hallucination: the patient described seeing indoor and outdoor scenes that included views of the neighborhood he lives in. By contrast, stimulating the more lateral aspect of the basal temporal lobe caused distortion of the patient's perception of faces, as recently reported (Parvizi et al., 2012). Our results support the causal role of the PPA in the perception of visual scenes, demonstrate that electrical stimulation of higher order visual areas can induce complex hallucinations, and also reaffirm direct electrical brain stimulation as a tool to assess the function of the human cerebral cortex.

24 December 2020 in New England Journal of Medicine
Verified
Journal Article
Closed access
PPPage B. Pennell
Page B. Pennell
JFJacqueline A. French
Jacqueline A. French
RMRyan C. May
Ryan C. May
EGElizabeth Gerard
Elizabeth Gerard
LKLaura Kalayjian
Laura Kalayjian
KMKimford J. Meador
Kimford J. Meador
Among women with epilepsy, studies regarding changes in seizure frequency during pregnancy have been limited by the lack of an appropriate nonpregnant comparator group to provide data on the natural course of seizure frequency in both groups.

1 July 2018 in Epilepsy & Behavior
Verified
Journal Article
Closed access
KMKimford J. Meador
Kimford J. Meador
PPPage B. Pennell
Page B. Pennell
RMRyan C. May
Ryan C. May
EGElizabeth Gerard
Elizabeth Gerard
LKLaura Kalayjian
Laura Kalayjian
DIDominic M. Ippolito
Dominic M. Ippolito

16 December 2021 in Neurology Genetics
Verified
Journal Article
Open access
PDF file
DMDianalee McKnight
Dianalee McKnight
SBSara Bristow
Sara Bristow
RTRebecca M. Truty
Rebecca M. Truty
AMAna Morales
Ana Morales
MSMolly Stetler
Molly Stetler
SASwaroop Aradhya
Swaroop Aradhya
Background and Objectives Although genetic testing among children with epilepsy has demonstrated clinical utility and become a part of routine testing, studies in adults are limited. This study reports the diagnostic yield of genetic testing in adults with epilepsy. Methods Unrelated individuals aged 18 years and older who underwent diagnostic genetic testing for epilepsy using a comprehensive, next-generation sequencing-based, targeted gene panel (range 89–189 genes) were included in this cross-sectional study. Clinical information, provided at the discretion of the ordering clinician, was reviewed and analyzed. Diagnostic yield was calculated for all individuals including by age at seizure onset and comorbidities based on clinician-reported information. The proportion of individuals with clinically actionable genetic findings, including instances when a specific treatment would be indicated or contraindicated due to a diagnostic finding, was calculated. Results Among 2,008 individuals, a diagnostic finding was returned for 218 adults (10.9%), with clinically actionable findings in 55.5% of diagnoses. The highest diagnostic yield was in adults with seizure onset during infancy (29.6%, 0–1 year), followed by in early childhood (13.6%, 2–4 years), late childhood (7.0%, 5–10 years), adolescence (2.4%, 11–17 years), and adulthood (3.7%, ≥18 years). Comorbid intellectual disability (ID) or developmental delay resulted in a high diagnostic yield (16.0%), most notably for females (19.6% in females vs 12.3% in males). Among individuals with pharmacoresistant epilepsy, 13.5% had a diagnostic finding, and of these, 57.4% were clinically actionable genetic findings. Discussion These data reinforce the utility of genetic testing for adults with epilepsy, particularly for those with childhood-onset seizures, ID, and pharmacoresistance. This is an important consideration due to longer survival and the complexity of the transition from pediatric to adult care. In addition, more than half of diagnostic findings in this study were considered clinically actionable, suggesting that genetic testing could have a direct impact on clinical management and outcomes.

5 December 2019 in Neurology
Verified
Journal Article
Closed access
PDF file
KMKimford J. Meador
Kimford J. Meador
PPPage B. Pennell
Page B. Pennell
RMRyan C. May
Ryan C. May
LMLinda Van Marter
Linda Van Marter
TMThomas F. McElrath
Thomas F. McElrath
FGfor the MONEAD Investigator Group
for the MONEAD Investigator Group
Objective To examine occurrence of severe adverse fetal outcomes (SAO), including fetal loss and major congenital malformations (MCMs), in pregnant women with epilepsy (PWWE) vs healthy pregnant women (HPW). Methods The Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) study is an NIH-funded, prospective, observational, multicenter investigation of pregnancy outcomes for both mother and child, which enrolled women December 2012 through January 2016. Results The 351 PWWE had 365 conceptions, and 105 HPW had 109 conceptions. SAOs occurred more often in PWWE (7.9%) vs HPW (1.9%) (p = 0.025) with odds ratio (OR) 4.45 (95% confidence intervals [CI] 1.04–19.01). There were no significant differences for fetal loss (2.8% vs 0%, p = 0.126) or MCMs (5.2% vs 1.9%, p = 0.185; OR 2.86, 95% CI 0.65–12.53) individually. No fetal losses in PWWE appeared to be related to acute seizures. Outcomes were not affected by periconceptional folate, unplanned/unwanted pregnancies, prior maternal pregnancy history, or antiepileptic drug (AED) blood levels, except for an AED level effect for fetal loss that appeared to be due to polytherapy. Combined maternal or paternal family history of MCM was marginally associated with increased SAOs (p = 0.046). Conclusions The findings provide additional information on risks of SAOs in PWWE, assessing effects of both AED levels and periconceptional folate. Group differences in average enrollment gestational age could have affected fetal loss results. Analyses are limited by small sample sizes as the MONEAD study was not powered for these secondary outcomes. The large majority of pregnancies in women with epilepsy do not have SOAs.